Reata Pharmaceuticals Stock Forecast - Accumulation Distribution
| RETADelisted Stock | USD 172.36 0.02 0.01% |
Reata Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Reata Pharmaceuticals stock prices and determine the direction of Reata Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Reata Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Reata |
Most investors in Reata Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Reata Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Reata Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
The accumulation distribution (A/D) indicator shows the degree to which Reata Pharmaceuticals is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Reata Pharmaceuticals to determine if accumulation or reduction is taking place in the market. This value is adjusted by Reata Pharmaceuticals trading volume to give more weight to distributions with higher volume over lower volume.| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 1549.87 | 8.0E-4 |
| Check Reata Pharmaceuticals Volatility | Backtest Reata Pharmaceuticals | Information Ratio |
Reata Pharmaceuticals Trading Date Momentum
| On April 19 2024 Reata Pharmaceuticals was traded for 172.36 at the closing time. The top price for the day was 172.46 and the lowest listed price was 172.32 . There was no trading activity during the period 0.0. Lack of trading volume on April 19, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.01% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Reata Pharmaceuticals to competition
Reata Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reata Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reata Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reata Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Reata Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Reata Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reata Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reata Pharmaceuticals stock market strength indicators, traders can identify Reata Pharmaceuticals entry and exit signals to maximize returns.
Reata Pharmaceuticals Risk Indicators
The analysis of Reata Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Reata Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting reata stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.16 | |||
| Semi Deviation | 0.3755 | |||
| Standard Deviation | 6.81 | |||
| Variance | 46.43 | |||
| Downside Variance | 2.37 | |||
| Semi Variance | 0.141 | |||
| Expected Short fall | (2.35) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Reata Stock
If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |